377 related articles for article (PubMed ID: 25617726)
1. Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone.
Kang DW; DiBaise JK; Ilhan ZE; Crowell MD; Rideout JR; Caporaso JG; Rittmann BE; Krajmalnik-Brown R
Anaerobe; 2015 Jun; 33():33-41. PubMed ID: 25617726
[TBL] [Abstract][Full Text] [Related]
2. Structural changes in the gut microbiome of constipated patients.
Zhu L; Liu W; Alkhouri R; Baker RD; Bard JE; Quigley EM; Baker SS
Physiol Genomics; 2014 Sep; 46(18):679-86. PubMed ID: 25073603
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls.
Jalanka J; Major G; Murray K; Singh G; Nowak A; Kurtz C; Silos-Santiago I; Johnston JM; de Vos WM; Spiller R
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669509
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Gut Microbiome and Metabolite Characteristics in Patients with Slow Transit Constipation.
Tian H; Chen Q; Yang B; Qin H; Li N
Dig Dis Sci; 2021 Sep; 66(9):3026-3035. PubMed ID: 32767153
[TBL] [Abstract][Full Text] [Related]
5. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
[TBL] [Abstract][Full Text] [Related]
6. A Randomized, Double-Blind, Placebo-Controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients.
Christie J; Shroff S; Shahnavaz N; Carter LA; Harrison MS; Dietz-Lindo KA; Hanfelt J; Srinivasan S
Am J Gastroenterol; 2017 Feb; 112(2):356-364. PubMed ID: 27922028
[TBL] [Abstract][Full Text] [Related]
7. Assessing the colonic microbiome, hydrogenogenic and hydrogenotrophic genes, transit and breath methane in constipation.
Wolf PG; Parthasarathy G; Chen J; O'Connor HM; Chia N; Bharucha AE; Gaskins HR
Neurogastroenterol Motil; 2017 Oct; 29(10):1-9. PubMed ID: 28295896
[TBL] [Abstract][Full Text] [Related]
8. Lubiprostone: chloride channel activator for chronic constipation.
Rivkin A; Chagan L
Clin Ther; 2006 Dec; 28(12):2008-21. PubMed ID: 17296458
[TBL] [Abstract][Full Text] [Related]
9. Zengye decoction induces alterations to metabolically active gut microbiota in aged constipated rats.
Liu D; Lin L; Lin Y; Zhong Y; Zhang S; Liu W; Zou B; Liao Q; Xie Z
Biomed Pharmacother; 2019 Jan; 109():1361-1371. PubMed ID: 30551387
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
Tan AH; Chong CW; Lim SY; Yap IKS; Teh CSJ; Loke MF; Song SL; Tan JY; Ang BH; Tan YQ; Kho MT; Bowman J; Mahadeva S; Yong HS; Lang AE
Ann Neurol; 2021 Mar; 89(3):546-559. PubMed ID: 33274480
[TBL] [Abstract][Full Text] [Related]
11. Short Chain Fatty Acids Effect on Chloride Channel ClC-2 as a Possible Mechanism for Lubiprostone Intestinal Action.
Catalán MA; Julio-Kalajzić F; Niemeyer MI; Cid LP; Sepúlveda FV
Cells; 2020 Jul; 9(8):. PubMed ID: 32722648
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
Jamal MM; Adams AB; Jansen JP; Webster LR
Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
[TBL] [Abstract][Full Text] [Related]
13. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls.
Saad RJ; Rao SS; Koch KL; Kuo B; Parkman HP; McCallum RW; Sitrin MD; Wilding GE; Semler JR; Chey WD
Am J Gastroenterol; 2010 Feb; 105(2):403-11. PubMed ID: 19888202
[TBL] [Abstract][Full Text] [Related]
14. Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion.
Zhuang M; Shang W; Ma Q; Strappe P; Zhou Z
Mol Nutr Food Res; 2019 Dec; 63(23):e1801187. PubMed ID: 31556210
[TBL] [Abstract][Full Text] [Related]
15. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
[TBL] [Abstract][Full Text] [Related]
16. Microbiota benefits after inulin and partially hydrolized guar gum supplementation: a randomized clinical trial in constipated women.
Linetzky Waitzberg D; Alves Pereira CC; Logullo L; Manzoni Jacintho T; Almeida D; Teixeira da Silva ML; Matos de Miranda Torrinhas RS
Nutr Hosp; 2012; 27(1):123-9. PubMed ID: 22566311
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
Front Immunol; 2020; 11():1994. PubMed ID: 32973805
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
Johanson JF; Morton D; Geenen J; Ueno R
Am J Gastroenterol; 2008 Jan; 103(1):170-7. PubMed ID: 17916109
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
[TBL] [Abstract][Full Text] [Related]
20. Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit.
Müller M; Hermes GDA; Canfora EE; Smidt H; Masclee AAM; Zoetendal EG; Blaak EE
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G361-G369. PubMed ID: 31869241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
